Four eburicane-type triterpenoids with malonyl modifications, namely irpexoates A-D (1-4), were isolated from the fruiting bodies of the medicinal fungus Irpex lacteus. The structures of the new compounds were established by extensive spectroscopic methods, including 1D and 2D NMR, HRESIMS spectroscopic analysis. Irpexoate B (2) displayed weak cytotoxicity against four human cancer cell lines (A-549, SMMC-7721, MCF-7, SW480) with IC 50 values varying from 22.9 to 34.0 lM, and irpexoate D (4) showed weak cytotoxicity against the human cancer cell line SW480 with an IC 50 value of 35.2 lM.
Introduction
Natural products from higher fungi (mushroom) are regarded as a vital source of lead compounds in the field of drug research and development [1] . The fungus Irpex lacteus is widely used in China as a folk medicine [2] . Previously chemical investigation on this fungus major focused on secondary metabolites from culture broth [3, 4] , while the study on the fruiting bodies remained untapped.
Triterpenoids are one of the largest groups of secondary metabolites from higher fungi. To the best of our knowledge, lanostane-type triterpenoids are by far the most diverse category of higher fungi-derived triterpenoids. This type of triterpenes always encounters in the genus Ganoderma and the fungus Poria cocos [1] . However, eburicane-type triterpenes, which also can be considered as 24-methyl lanostanes, have rarely been found from fungi. Triterpenoids with malonyl modification are not prevalent Electronic supplementary material The online version of this article (https://doi.org/10.1007/s13659-018-0160-3) contains supplementary material, which is available to authorized users. in fungal metabolites. From biosynthetic point, the malonyl moieties were introduced by the precursor malonyl-CoA, which was a key intermediate in the pathways of fatty acid biosynthesis and fatty acid elongation, and also a key signaling molecule in mammalian cells [5] . As our continuous efforts to search promising lead compounds from mushroom, four malonyl modified eburicanes, namely irpexoates A-D (1-4) (Fig. 1) , were isolated from the fruiting bodies of the medicinal fungus I. lacteus. Herein, we report the isolation, structure elucidation, and cytotoxicity against five human cancer lines of the isolates irpexoates A-D (1-4). 3 ones, four olefinic ones, three carbonyls, and a ketal carbon (d C 107.7, C-23). All these spectroscopic features implied the presence of an eburicane skeleton in compound 1. Exhaustive analysis of the 2D NMR spectra furnished the establishment of the structure of 1. The HMBC correlations from H 3 -31 to C-23, C-24 (d C 157.8), and C-25 (d C 124.1), from H 3 -27 to C-24, C-25, and C-26 (d C 172.5), from H-16 (d H 4.51) to C-23 (Fig. 2) indicated the existence of a 26,23-lactone, and a 16,23-epoxy group, which constructing a spiro ring system with C-23 as the shared carbon. The HMBC correlations from H 3 -19 to C-1 (d C 71.3), C-9 (d C 135.1), from H 3 -28, H 3 -29 to C-3 (d C 81.0), and from H 3 -30 to C-8 (d C 134.8) (Fig. 2 ) revealed that C-1 and C-3 were oxygenated, and a double bond was assigned at the positions C-8-C-9. Apart from the signals assigned to the eburicane skeleton, the remained three carbon signals, i.e. two carbonyls at d C 167.8 (C-1 0 ) and 169.7 (C-3 0 ), and a methylene at d C 41.1 (C-2 0 ) were due to a malonyl moiety attached to C-3, which was supported by the HMBC correlations from H- (Fig. 3) . As for the configuration of C-3, the broad triplet of H-3 with a small coupling constant (3.0 Hz) indicated the b orientation for H-3, which can be seen as a consequence of the nearly same dihedral angle between H-3/H-2a, and H-3/H-2b when H-3 adopted b orientation (Fig. 3) . Therefore, compound 1 was determined as shown in Fig. 1 , and given the name irpexoate A.
Results and Discussion
The white amorphous powder compound 2, named irpexoate B, possessed the molecular formula of C 35 Tables 1, 2) showed highly similarities to those of 1, indicating that these two compounds possessed identical carbon scaffold and substitution patterns. Compared to 1, the presence of an additional methoxy group at d C 52.4 (C-4 0 ) in 2, along with the HMBC correlation from H 3 -4 (Fig. 2) revealed that the terminal carboxylic acid group was methyl-esterified in 2. Other characteristic ROESY correlations suggested that the stereochemistry of chiral centers in 2 was identical with those of 1. As describe above, compound 2 was determined as shown in Fig. 1 13 C NMR data of 3 to those of 1 (Tables 1 , 2) revealed that 3 was an analogue of 1. Carefully analysis of the HMBC and 1 H-1 H COSY spectra of 3 revealed the existence of a conjugated diene locating at C-7-C-8-C-9-C-11, which was ascertainable by the HMBC correlations from the olefinic protons H-7 (d H 5.49) and H-11 (d H 6.30) to C-8 (d C 141.8), C-9 (d C 144.2) as well as the 1 H-1 H COSY cross peaks between H-6/H-7, H-11/H-12 (Fig. 2) . The stereochemistry of 3 was assigned by a ROESY experiment and coupling constants analysis. The diagnostic ROESY correlations between H-1/H-5, H 3 -18/H-20, H 3 -18/H 3 -31, H 3 -30/H-16/H-17 indicated that both H-1 and H-16 were a orientation, and the spiro carbon C-23 was R* configuration (Fig. 3 ). The triplet peak of H-3 (d H 4.85) with small coupling constant (3.0 Hz) suggested the malonate moiety at the axial position. Therefore, compound 3 was established as shown in Fig. 1 (Table 3 ). However, compounds 1 and 3 were devoid of cytotoxicity. Thus, the conclusion could be drawn that the absence of methoxy group in the malonyl moiety attenuated the cytotoxicity.
Experimental

General Experimental Procedures
Optical rotations were obtained on a JASCO P-1020 digital polarimeter (Horiba, Kyoto, Japan). UV spectra were recorded on a Shimadzu UV-2401PC UV-visible recording spectrophotometer (Shimadzu, Kyoto, Japan). A Tenor 27 spectrophotometer (Bruker Optics GmbH, Ettlingen, Germany) was used for scanning IR spectroscopy using KBr pellets. 1D and 2D NMR spectra were obtained on Bruker DRX 500 MHz and Avance III 600 MHz spectrometers (Bruker Corporation, Karlsruhe, Germany). HRESIMS were recorded on an Agilent 6200 Q-TOF MS system (Agilent Technologies, Santa Clara, CA, USA). Sephadex LH-20 (Amersham Biosciences, Uppsala, Sweden) and silica gel (Qingdao Haiyang Chemical Co., Ltd, Qingdao, China) were used for column chromatography (CC). Medium pressure liquid chromatography (MPLC) was performed on a Büchi Sepacore System equipped with pump manager C-615, pump modules C-605 and fraction collector C-660 (Büchi Labortechnik AG, Flawil, Switzerland), and columns packed with Chromatorex C-18 (dimensions 450 mm 9 i.d. 14 mm, particle size: 40-75 lm, Fuji Silysia Chemical Ltd., Kasugai, Japan). Preparative high performance liquid chromatography (prep-HPLC) were performed on an Agilent 1260 liquid chromatography system equipped with a Zorbax SB-C18 column (particle size 5 lm, dimension 150 mm 9 i.d. 9.4 mm, flow rate 7 ml min -1 , respectively) and a DAD detector (Agilent Technologies).
Fungal Material
The fungus Irpex lacteus was collected from the Wangtianshu Scenic Area, Xishuangbanna, Yunnan Province in July 2014, and authenticated by Prof. Yu-Cheng Dai (Beijing Forestry University), who is a mushroom specialist. A voucher specimen of I. lacteus was deposited at the Mushroom Bioactive Natural Products Research Group in Kunming Institute of Botany (No. HFG 201407).
Extraction and Isolation
The dry fruiting bodies of I. lacteus (1.47 kg) was pulverized and macerated five times with 95% EtOH at room temperature. The extract was evaporated under reduced pressure and partitioned between EtOAc and water for three times to give an EtOAc layer (53 g). The crude extract was eluted on MPLC with a stepwise gradient of MeOH/H 2 O (20-100%) to afford eight fractions (A-H).
Fraction E was applied to silica gel column chromatography eluting with petroleum ether/acetone (5:1-2:1) to give ten subfractions (E1-E10). Subfraction E5 was purified by prep-HPLC (MeCN/H 2 O: 45-65%, 7 mL min -1 , 20 min) to yield compound 4 (1.8 mg, t R-= 13.8 min). Fraction F was subjected to normal silica gel CC (CHCl 3 /MeOH, 40:1-1:1) to furnish seven subfractions (F1-F7). Subfraction F6 was purified on prep-HPLC (MeCN/H 2 O: 65%, isocratic, 18 mL min -1 , 20 min) to yield compound 1 (26.6 mg, t R = 9.5 min). Compound 2 (17.0 mg, t R = 12.9 min) was purified from subfraction F1 by prep-HPLC (MeCN/H 2 O: 55-75%, 7 mL min -1 , 20 min). Subfraction F4 was fractionated into five subfractions (F4a-F4e) by Sephadex LH-20, eluting with CHCl 3 -MeOH (1:1). Subfraction F4e was separated using silica gel CC (CHCl 3 /MeOH, 100:1 -10:1) to afford eight subfractions (F4e1-F4e8). Subfraction F4e5 was fractionated by Sephadex LH-20 (acetone) to give six subfractions (F4e5a-F4e5f). Subfraction F4e5c was further purified using prep-HPLC with a solvent gradient of 45-65% MeCN in H 2 O over 20 min, flow rate 7 mlÁmin -1 , to yield compound 3 (3.0 mg, t R = 12.9 min). 
Spectroscopic Data of Compounds
Cytotoxicity Assays
Human myeloid leukemia HL-60 cells, lung cancer A-549 cells, hepatocellular carcinoma SMMC-7721 cells, breast cancer MCF-7 cells, and colon cancer SW480 cell lines were used in the cytotoxic assay. All the cells were cultured in DMEM or RPMI-1640 medium (Hyclone, USA), supplemented with 10% fetal bovine serum (Hyclone, USA) in 5% CO 2 at 37°C. The cytotoxicity assay was performed according to the MTS (3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfopheny)-2H-tetrazolium) method in 96-well microplates. Briefly, 100 lL of adherent cells was seeded into each well of 96-well cell culture plates and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just before drug addition to an initial density of 1 9 105 cells ml -1 . Each tumor cell line was exposed to the tested compounds dissolved in DMSO at various concentrations in triplicate for 48 h, with cisplatin (Sigma, USA) as a positive control. After compound treatment, cell viability was detected and a cell growth curve was graphed. IC 50 values were calculated by Reed and Muench's method [6] .
